Levi Strauss & CO Form 4 insider transactions
NYSE
Director David Marberger acquired 68 shares of Levi Strauss & Co. Class A Common Stock via dividend equivalent rights.
NYSE
Director Troy Alstead acquired additional Class A and Class B common stock units via dividend equivalent rights.
NYSE
Director Jeffrey J. Jones II acquired 62 shares of Levi Strauss & Co. Class A Common Stock via dividend equivalent rights.
NYSE
EVP and Chief Product Officer Karyn Hillman sold 38,938 shares of Levi Strauss & Co. common stock.
NYSE
Director Elliott Rodgers acquired additional shares of Levi Strauss & Co. through a dividend reinvestment program and dividend equivalent rights.
NYSE
Levi Strauss & Co. SVP, Global Controller Timothy Joseph Davis acquired 18,001 restricted stock units on May 1, 2026, as detailed in a Form 4 filing.
NYSE
Director Elliott Rodgers acquired 8,381 restricted stock units in Levi Strauss & Co. as part of an equity compensation grant.
NYSE
Director Joshua E. Prime acquired 8,381 restricted stock units in Levi Strauss & Co. as part of an equity compensation grant.
NYSE
Levi Strauss & Co. Director Patrick Artemis acquired 8,381 restricted stock units as part of an equity compensation grant.
NYSE
Director Jenny Ming acquired 8,381 restricted stock units in Levi Strauss & Co. as part of an equity compensation grant.
NYSE
Director David S. Marberger acquired 8,381 restricted stock units in Levi Strauss & Co. as part of an equity grant.
NYSE
Director Jeffrey J. Jones II acquired 8,381 restricted stock units in Levi Strauss & Co. as part of an equity compensation grant.
NYSE
Levi Strauss & Co. director Daniel W. Geballe acquired 8,381 restricted stock units as part of an equity grant.
NYSE
Director Yael Garten acquired 8,381 restricted stock units in Levi Strauss & Co. as part of an equity compensation grant.
NYSE
Director Robert Eckert acquired 8,381 restricted stock units in Levi Strauss & Co. as part of an equity grant.
NYSE
Director Jill Beraud acquired 8,381 restricted stock units in Levi Strauss & Co. as part of an equity compensation grant.
NYSE
Levi Strauss & Co. director Troy Alstead acquired 13,170 restricted stock units as part of an equity compensation grant.
NYSE
EVP and Chief Financial & Growth Officer Harmit J. Singh sold 231,767 shares of Levi Strauss & Co. stock over two days.
NYSE
Levi Strauss Director Christopher J. McCormick acquired additional dividend equivalent rights for Class A and Class B Common Stock.
NYSE
Levi Strauss & Co. Director Jill Beraud acquired dividend equivalent rights for Class A and Class B Common Stock on February 25, 2026.
NYSE
Levi Strauss & Co. Director Joshua E Prime acquired 125 shares of Class A Common Stock through dividend equivalent rights.
NYSE
Levi Strauss & Co. Director Patrick Artemis acquired 89 shares of Class A Common Stock through dividend equivalent rights, increasing direct beneficial ownership to 14,265 shares.
NYSE
Levi Strauss & Co. Director Jenny J. Ming acquired additional Class A and Class B shares through dividend equivalent rights.
NYSE
Levi Strauss & Co. Director David S. Marberger acquired 93 shares of Class A Common Stock through dividend equivalent rights, increasing his direct beneficial ownership to 22,844 shares.
NYSE
Levi Strauss & Co. Director Robert Eckert reported the acquisition of dividend equivalent rights for Class A and Class B Common Stock.
NYSE
Levi Strauss & Co. Director Yael Garten acquired 98 shares of Class A Common Stock through dividend equivalent rights on February 25, 2026.
NYSE
Levi Strauss & Co. Director Troy Alstead increased his beneficial ownership through the acquisition of dividend equivalent rights for both Class A and Class B Common Stock.
NYSE
Levi Strauss & Co. Director Daniel W. Geballe acquired 74 shares of Class A Common Stock through dividend equivalent rights.
NYSE
Levi Strauss & Co. Director Jeffrey J. Jones II acquired 13 shares of Class A Common Stock through dividend equivalent rights.
NYSE
Levi Strauss & Co. Director Elliott Rodgers increased his direct ownership of Class A Common Stock through dividend reinvestment and dividend equivalent rights.